The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
This seminal paper (2014) introduces the entropic brain hypothesis intending to build a bridge between neuroscience and psychoanalytic theories. The entropic brain hypothesis proposes two different forms of cognition, one being more 'critical' and unconstrained (whilst under psychedelics). It has become one of the major theories underlying our understanding of how psychedelics exert their therapeutic effects.
Authors
- Enzo Tagliazucchi
- Robin Carhart-Harris
- David Nutt
Published
Abstract
Entropy is a dimensionless quantity that is used for measuring uncertainty about the state of a system but it can also imply physical qualities, where high entropy is synonymous with high disorder. Entropy is applied here in the context of states of consciousness and their associated neurodynamics, with a particular focus on the psychedelic state. The psychedelic state is considered an exemplar of a primitive or primary state of consciousness that preceded the development of modern, adult, human, normal waking consciousness. Based on neuroimaging data with psilocybin, a classic psychedelic drug, it is argued that the defining feature of “primary states” is elevated entropy in certain aspects of brain function, such as the repertoire of functional connectivity motifs that form and fragment across time. Indeed, since there is a greater repertoire of connectivity motifs in the psychedelic state than in normal waking consciousness, this implies that primary states may exhibit “criticality,” i.e., the property of being poised at a “critical” point in a transition zone between order and disorder where certain phenomena such as power-law scaling appear. Moreover, if primary states are critical, then this suggests that entropy is suppressed in normal waking consciousness, meaning that the brain operates just below criticality. It is argued that this entropy suppression furnishes normal waking consciousness with a constrained quality and associated metacognitive functions, including reality-testing and self-awareness. It is also proposed that entry into primary states depends on a collapse of the normally highly organized activity within the default-mode network (DMN) and a decoupling between the DMN and the medial temporal lobes (which are normally significantly coupled). These hypotheses can be tested by examining brain activity and associated cognition in other candidate primary states such as rapid eye movement (REM) sleep and early psychosis and comparing these with non-primary states such as normal waking consciousness and the anaesthetized state.
Research Summary of 'The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs'
Introduction
Carhart-Harris and colleagues present a synthetic theory—the entropic brain hypothesis—that links principles from physics, neurobiology and psychoanalysis to explain differences between normal adult waking consciousness and a class of regressive or ‘‘primary’’ conscious states (for example, the psychedelic state, REM sleep and early psychosis). The paper frames entropy, in the information-theoretical sense, as a quantitative index of a brain's uncertainty or disorder, and proposes that subjective experiences of puzzlement or loosened reality-testing accompany increased system entropy. It positions self-organised criticality and Friston's free-energy ideas as conceptual scaffolding for relating dynamical brain properties to conscious style. The study sets out to argue that the psychedelic state exemplifies a high-entropy or near-critical mode of brain function, and to map candidate neural correlates of the ‘‘ego’’ or self-boundary—notably activity, synchrony and coupling within the default mode network (DMN) and between the DMN and the medial temporal lobes (MTLs). Using previously published neuroimaging findings (ASL, BOLD fMRI and MEG) with psilocybin alongside theoretical argument, the authors propose testable hypotheses about how DMN integrity, DMN–MTL coupling, oscillatory activity (especially PCC alpha) and measures of network metastability and entropy distinguish primary from secondary consciousness. A secondary aim is to show how psychedelics can serve as an experimental tool to probe psychoanalytic constructs within cognitive neuroscience.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- Authors
- APA Citation
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8. https://doi.org/10.3389/fnhum.2014.00020
References (25)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Leech, R., Erritzoe, D. et al. · Schizophrenia Bulletin (2012)
Carhart-Harris, R. L., Friston, K. J. · Brain (2010)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Substance Use (2010)
Carhart-Harris, R. L., Williams, T. M., Sessa, B. et al. · Journal of Psychopharmacology (2010)
William Deakin, J. F., Lees, J., McKie, S. et al. · JAMA Psychiatry (2008)
Dyck, E. · Canadian Journal of Psychiatry (2005)
Gonza ´lez-Maeso, J., Weisstaub, N. V., Zhou, M. et al. · Neuron (2007)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Show all 25 referencesShow fewer
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kometer, M., Schmidt, A., Bachmann, R. et al. · Biological Psychiatry (2012)
Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
Mangini, M. · Journal of Psychoactive Drugs (2011)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
Nichols, D. E. · Pharmacology and Therapeutics (2004)
King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)
Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)
Van Amsterdam, J., Opperhuizen, A., Van Den Brink, W. · Regulatory Toxicology and Pharmacology (2011)
Van Wel, J. H. P., Kuypers, K. P. C., Theunissen, E. L. et al. · PLOS ONE (2012)
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A. et al. · NeuroReport (1998)
Cited By (217)
Papers in Blossom that reference this study
Moreno, F. A., Allen, K. E., Wiegand, C. B. et al. · Journal of Psychopharmacology (2026)
Prochazkova, L., Marschall, J., Lippelt, D. P. et al. · Neuropharmacology (2026)
Scholle, P., Wenke, Š., Nekovářová, T. et al. · Journal of Psychopharmacology (2026)
Lewis-Healey, E., Pallavicini, C., Cavanna, F. et al. · Journal of Cognitive Neuroscience (2025)
Irrmischer, M., Aqil, M., Luan, L. et al. · Journal of Neuroscience (2025)
Martens, M. A. G., Cunha, B. G., Erritzoe, D. et al. · Translational Psychiatry (2025)
Prochazkova, L., van Elk, M., Marschall, J. et al. · Neuropsychopharmacology (2025)
Egger, K., Meling, D., Polat, F. et al. · Imaging Neuroscience (2025)
Vohryzek, J., Luppi, A. I., Atasoy, S. et al. · Neuropsychopharmacology (2025)
Tylš, F., Páleníček, T., Klučková, T. et al. · Pharmacological Reports (2025)
Show all 217 papersShow fewer
Roseby, W., Kettner, H., Roseman, L. et al. · Frontiers in Psychology (2025)
Suay, D., Aicher, H. D., Kometer, M. et al. · NeuroImage (2025)
Timmermann, C., Sanders, J. W., Reydellet, D. et al. · Neuroscience of Consciousness (2025)
Singleton, S. P., Timmermann, C., Luppi, A. I. et al. · Communications Biology (2025)
Piccinini, J. I., Perl, Y. S., Pallavicini, C. et al. · Communications Biology (2025)
Stoliker, D., Novelli, L., Khajehnejad, M. et al. · Biorxiv (2025)
Safron, A., Juliani, A., Reggente, N. et al. · Neuroscience of Consciousness (2025)
Brouwer, A., Brown, J., Erowid, E. et al. · npj Mental Health Research (2025)
Zeifman, R. J., Spriggs, M. J., Kettner, H. et al. · Scientific Reports (2025)
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Lyons, T., Spriggs, M. J., Kerkelä, L. et al. · Biorxiv (2024)
Caspani, G., Ruffell, S. G. D., Tsang, WF. et al. · Pharmacological Research (2024)
McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)
Nicol, G. E. · Nature (2024)
Shinozuka, K., Tewarie, P. K. B., Luppi, A. et al. · Biorxiv (2024)
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Juliani, A., Chelu, V., Graesser, L. et al. · Biorxiv (2024)
Peill, J. M., Marguilho, M., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)
Orłowski, P., Hobot, J., Ruban, A. et al. · Psychophysiology (2024)
Tolle, H. M., Farah, J. C., Mallaroni, P. et al. · Network Neuroscience (2024)
Pasquini, L., Simon, A. J., Gallen, C. L. et al. · Biorxiv (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Barba, T., Kettne, H., Radu, C. et al. · Scientific Reports (2024)
Murray, C., Frohlich, J, Haggarty, C. J., Tare, I. et al. · Neuropsychopharmacology (2024)
Mediano, P. A. M., Rosas, F. E., Timmermann, C. et al. · ACS Chemical Neuroscience (2024)
Mallaroni, P., Mason, N. L., Kloft, L. et al. · NeuroImage (2024)
Harduf, A., Panishev, G., Harel, E. V. et al. · Scientific Reports (2023)
Rosas, F. E., Mediano, P. A. M., Timmermann, C. et al. · Biorxiv (2023)
Haikazian, S., Chen-Li, D., Johnson, D. et al. · Psychiatry Research (2023)
Greń, J., Tylš, F., Lasocik, M. et al. · Frontiers in Psychology (2023)
Buchborn, T., Kettner, H., Kartner, L. et al. · Frontiers in Neuroscience (2023)
Mortaheb, S., Fort, L. D., Mason, N. L. et al. · Biological Psychiatry (2023)
Lewis, B. R., Garland, E. L., Byrne, K. et al. · Journal of Pain and Symptom Management (2023)
Vohryzek, J., Cabral, J., Timmermann, C. et al. · National Science Review (2023)
Pereira, L. · European Neuropsychopharmacology (2023)
McCulloch, D. E-W., Olsen, A. S., Ozenne, B. et al. · MedRvix (2023)
Girn, M., Rosas, F. E., Daws, R. E. et al. · Trends in Cognitive Sciences (2023)
Herzog, R., Mediano, P. A. M., Rosas, F. E. et al. · Scientific Reports (2023)
Michael, P., Luke, D., Robinson, O. · Frontiers in Psychology (2023)
Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Kaup, K. K., Vasser, M., Tulver, K. et al. · Frontiers in Psychiatry (2023)
Eckernäs, E., Timmermann, C., Carhart-Harris, R. et al. · Philosophy and the Mind Sciences (2023)
Ruffini, G., Damiani, G., Lozano-Soldevilla, D. et al. · PLOS ONE (2023)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Luppi, A. I., Vohryzek, J., Kringelbach, M. L. et al. · Communications Biology (2023)
Peterson, A., Largent, E. A., Sisti, D. et al. · AJOB Neuroscience (2022)
Olsen, A. S., Ozenne, B., Madsen, M. K. et al. · NeuroImage (2022)
Ortiz Bernal, A. M., Raison, C. L., Lancelotta, R. et al. · Frontiers in Psychiatry (2022)
Wall, M., Nutt, D. J., Kaelen, M. et al. · Journal of Psychopharmacology (2022)
Gukasyan, N., Schreyer, C. C., Griffiths, R. R. et al. · Current Psychiatry Reports (2022)
Guss, J. · Psychoanalytic Dialogues (2022)
Bedford, P., Hauke, D. J., Wang, Z. et al. · Neuropsychopharmacology (2022)
Thal, S. B., Wieberneit, M., Sharbanee, J. M. et al. · Journal of Psychopharmacology (2022)
Madsen, M. K., Ozenne, B., Armand, S. et al. · Frontiers in Psychology (2022)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)
Kałużna, A., Schlosser, M., Gulliksen Craste, E. et al. · Journal of Psychedelic Studies (2022)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
Sanz, C., Cavanna, F., Muller, S. et al. · Psychopharmacology (2022)
Amada, N., Shane, J. · Journal of Humanistic Psychology (2022)
Yaden, D. B., Earp, D., Graziosi, M. et al. · Frontiers in Psychology (2022)
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
Tagliazucchi, E. · Frontiers in Pharmacology (2022)
Ciauncia, A., Safron, A. · Psyarxiv (2022)
Sarparast, A., Thomas, K., Malcolm, B. et al. · Psychopharmacology (2022)
Elman, I., Borsook, D., Pustilink, A. · Neuroscience and Biobehavioral Reviews (2022)
Argento, E., Socias, M. E., Hayashi, K. et al. · International Journal of Drug Policy (2022)
Vollenweider, F. X., Smallridge, J. W. · Pharmacopsychiatry (2022)
Barrett, F. S., Zhou, Y., Carbonaro, T. M. et al. · Frontiers in Neuroergonomics (2022)
Glynos, N. G., Pierce, J., Davis, A. K. et al. · Journal of Psychoactive Drugs (2022)
Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)
Whitfield, H. J. · Frontiers in Psychiatry (2021)
Cavanna, F., Muller, S., de la Fuente, L. A. et al. · Translational Psychiatry (2021)
Qiu, X., Minda, J. P. · Psyarxiv (2021)
Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)
Vejmola, Č., Tylš, F., Piorecká, V. et al. · Translational Psychiatry (2021)
Johnson, M. W., Gründer, G., Betzler, F. et al. · Current Addiction Reports (2021)
Rodríguez Arce, J. M., Winkelman, M. J. · Frontiers in Psychology (2021)
Zamani, A., Carhart-Harris, R. L., Christoff, K. · Neuropsychopharmacology (2021)
Dupuis, D. · Transcultural Psychiatry (2021)
Davis, A. K., Xin, Y., Sepeda, N. D. et al. · Chronic Stress (2021)
Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)
Greco, A., Gallitto, G., Rastelli, C. · Entropy (2021)
Rodan, S., Aouad, P., McGregor, I. S. et al. · OBM Neurobiology (2021)
Savino, A., Nichols, C. D. · Biorxiv (2021)
Michael, P., Luke, D., Robinson, O. · Frontiers in Psychology (2021)
Leptourgos, P., Bouttier, V., Denève, S. et al. · Psyarxiv (2021)
Van Elk, M., Fejer, G., Lempe, P. et al. · Psychopharmacology (2021)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. T. et al. · Translational Psychiatry (2021)
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A. et al. · NeuroImage (2021)
Sumner, R. L., Chacko, E., Mcmillan, R. et al. · Journal of Psychopharmacology (2021)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Pasquini, L., Luke, D., Harris, R. E. et al. · Frontiers in Human Neuroscience (2021)
Qiu, T. T., Minda, J. P. · Psyarxiv (2021)
Thomas, C. W., Blanco-Duque, C., Breant, B. et al. · Translational Psychiatry (2021)
Lehmann, M., Neumann, C., Wasserthal, S. et al. · Neuroscience of Consciousness (2021)
Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
González, J., Cavelli, M., Castro-Zaballa, S. et al. · ACS Pharmacology and Translational Science (2021)
Sanz, C., Pallavicini, C., Carrillo, F. et al. · Consciousness and Cognition (2021)
Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Ferris, J. A., Nutt, D. J. · Drug Science Policy and Law (2020)
Doss, M. K., May, D. G., Johnson, M. W. et al. · Scientific Reports (2020)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Greenway, K. T., Garel, N., Jerome, L. et al. · Expert Review of Clinical Pharmacology (2020)
Girn, M., Mills, C., Roseman, L. et al. · NeuroImage (2020)
Smith, W. R., Sisti, D. · Journal of Medical Ethics (2020)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)
Castellanos, J. P., Woolley, C., Bruno, K. A. et al. · Regional Anesthesia and Pain Medicine (2020)
Girn, M., Roseman, L., Bernhardt, B. et al. · Biorxiv (2020)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Association for Computing Machinery (2020)
Barnett, L., Muthukumaraswamy, S., Carhart-Harris, R. L. · NeuroImage (2020)
Heuschkel, K., Kuypers, K. P. C. · Frontiers in Psychiatry (2020)
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Murphy-Beiner, A., Soar, K. · Psychopharmacology (2020)
Ho, J. T., Preller, K. H., Lenggenhager, B. · Neuroscience and Biobehavioral Reviews (2020)
Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Kettner, H., Gandy, S., Haijen, E. C. H. M. et al. · International Journal of Environmental Research and Public Health (2019)
Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Pallavicini, C., Vilas, M. G., Villarreal, M. et al. · NeuroImage (2019)
Luoma, J. B., Sabucedo, P., Eriksson, J. et al. · Journal of Contextual Behavioral Science (2019)
Smigielski, L., Scheidegger, M., Kometer, M. et al. · NeuroImage (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Dipasquale, O., Selvaggi, P., Veronese, M. et al. · NeuroImage (2019)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Russ, S. L., Carhart-Harris, R. L., Maruyama, G. et al. · Psychology of Consciousness Theory Research and Practice (2019)
Polito, V., Stevenson, R. J. · PLOS ONE (2019)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Richards, W. A., Garcia-Romeu, A. · International Review of Psychiatry (2018)
Ezquerra-Romano, I. I., Lawn, W., Krupitsky, E. M. et al. · Neuropharmacology (2018)
Timmermann, C., Spriggs, M. J., Kaelen, M. et al. · Neuropharmacology (2018)
Zamberlan, F., Sanz, C., Pallavicini, C. et al. · Frontiers in Integrative Neuroscience (2018)
Prochazkova, L., Lippelt, D. P., Colzato, L. S. et al. · Psychopharmacology (2018)
Lyons, T., Carhart-Harris, R. L. · Frontiers in Psychology (2018)
Hendricks, P. S. · International Review of Psychiatry (2018)
Barrett, F. S., Preller, K. H., Kaelen, M. · International Review of Psychiatry (2018)
Bayne, T., Carter, O. · Neuroscience of Consciousness (2018)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Schenberg, E. E. · Frontiers in Pharmacology (2018)
Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)
Preller, K. H., Schilbach, L., Pokorny, T. et al. · Journal of Neuroscience (2018)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Kraehenmann, R., Nielson, E. M., May, D. G. et al. · Frontiers in Pharmacology (2018)
Sanz, C., Zamberlan, F., Erowid, E. et al. · Frontiers in Neuroscience (2018)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Bravermanová, A., Viktorinová, M., Tylš, F. et al. · Psychopharmacology (2018)
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Sumiyoshi, T., Kraehenmann, R., Pokorny, D. et al. · Frontiers in Pharmacology (2017)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Carhart-Harris, R. L., Roseman, L., Bolstridge, M. et al. · Scientific Reports (2017)
Winkelman, M. J. · Frontiers in Neuroscience (2017)
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R. et al. · Trends in Pharmacological Sciences (2017)
Argento, E., Strathdee, S. A., Tupper, K. et al. · BMJ Open (2017)
Bøhling, F. · International Journal of Drug Policy (2017)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Viol, A., Palhano-Fontes, F., Onias, H. et al. · Scientific Reports (2017)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Elsey, J. W. B. · Drug Science Policy and Law (2017)
Slevc, L. R., Barrett, F. S., Robbins, H. et al. · Frontiers in Psychology (2017)
Letheby, C., Gerrans, P. · Neuroscience of Consciousness (2017)
Kaelen, M., Lorenz, R., Barrett, F. S. et al. · Biorxiv (2017)
Millière, R. · Frontiers in Human Neuroscience (2017)
Liechti, M. E. · Neuropsychopharmacology (2017)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Kaelen, M. · Imperial College London (2017)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Pink-Hashkes, S., Van Rooij, I., Kwisthout, J. · CogSci (2017)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · Neuroscience and Biobehavioral Reviews (2016)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S. et al. · Journal of Psychopharmacology (2016)
Nichols, C. D., Nichols, D. E., Johnson, M. W. · Clinical Pharmacology and Therapeutics (2016)
Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)
Sweat, N. W., Bates, L. W., Hendricks, P. S. · Journal of Psychoactive Drugs (2016)
Family, N., Vinson, D., Vigliocco, G. et al. · Language Cognition and Neuroscience (2016)
Garcia-Romeu, A., Kersgaard, B., Addy, P. H. · Experimental and Clinical Psychopharmacology (2016)
Kaelen, M., Roseman, L., Kahan, J. et al. · European Neuropsychopharmacology (2016)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Dos Santos, R. G., Balthazar, F. M., Bouso, J. C. et al. · Journal of Psychopharmacology (2016)
Lebedev, A. V., Kaelen, M., L€ Ovd En, M. et al. · Human Brain Mapping (2016)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Nichols, D. E. · Pharmacological Reviews (2016)
Das, S., Barnwal, P., Ramasamy, A. et al. · Therapeutic Advances in Psychopharmacology (2016)
Speth, J., Speth, C., Kaelen, M. et al. · Journal of Psychopharmacology (2016)
Frecska, E., Bokor, P., Winkelman, M. J. · Frontiers in Pharmacology (2016)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Gallimore, A. R. · Frontiers in Human Neuroscience (2015)
Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
Kirchner, K. · Journal of Psychopharmacology (2014)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Roseman, L., Leech, R., Feilding, A. et al. · Frontiers in Human Neuroscience (2014)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.